BlackRock »

Sagimet Biosciences Inc-a shares owned by BlackRock

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 953k 2.77

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
NEA Management Company
Blue Owl Capital Holdings
Baker Bros. Advisors
Alyeska Investment Group
Citadel Advisors
Vanguard Group
BlackRock
BlackRock
Rock Springs Capital Management
Hillhouse Capital Advisors
Siren
Partner Fund Management
Bank of America Corporation
Ikarian Capital

View all funds holding Sagimet Biosciences Inc-a